Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04719273
Title Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Thomas Jefferson University

endometrial clear cell adenocarcinoma

endometrial carcinoma

endometrial adenocarcinoma

endometrial serous adenocarcinoma


Anastrozole + Onapristone

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.